109 related articles for article (PubMed ID: 9827922)
21. Transient abnormal myelopoiesis in Down's syndrome.
Kurahashi H; Hara J; Yumura-Yagi K; Tawa A; Kawa-Ha K
Leuk Lymphoma; 1992 Dec; 8(6):465-75. PubMed ID: 1297480
[TBL] [Abstract][Full Text] [Related]
22. Clinical, cytogenetic, and molecular characterization of a girl with some clinical features of Down syndrome resulting from a pure partial trisomy 21q22.11-qter due to a de novo intrachromosomal duplication.
Vaglio A; Milunsky A; Quadrelli A; Huang XL; Maher T; Mechoso B; Martínez S; Pagano S; Bellini S; Costabel M; Quadrelli R
Genet Test Mol Biomarkers; 2010 Feb; 14(1):57-65. PubMed ID: 20143912
[TBL] [Abstract][Full Text] [Related]
23. Application of fluorescence in situ hybridization to the identification of different marker chromosomes.
Verschraegen-Spae MR; Quack B; Rousseaux S; Pison H; Messiaen L; De Paepe A; Lespinasse J
Ann Genet; 1998; 41(1):5-10. PubMed ID: 9599644
[TBL] [Abstract][Full Text] [Related]
24. [Prenatal chromosome analysis using the FISH technique allows fetal aneuploidy detection within a few hours].
Steinborn A; Röddiger S; Born HJ; Baier P; Halberstadt E
Z Geburtshilfe Neonatol; 1996; 200(5):186-90. PubMed ID: 9035828
[TBL] [Abstract][Full Text] [Related]
25. Exploring polycythaemia vera with fluorescence in situ hybridization: additional cryptic 9p is the most frequent abnormality detected.
Najfeld V; Montella L; Scalise A; Fruchtman S
Br J Haematol; 2002 Nov; 119(2):558-66. PubMed ID: 12406101
[TBL] [Abstract][Full Text] [Related]
26. Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.
Brink DS
Adv Anat Pathol; 2006 Sep; 13(5):256-62. PubMed ID: 16998319
[TBL] [Abstract][Full Text] [Related]
27. Transient myeloproliferative disorder with partial trisomy 21.
Takahashi T; Inoue A; Yoshimoto J; Kanamitsu K; Taki T; Imada M; Yamada M; Ninomiya S; Toki T; Terui K; Ito E; Shimada A
Pediatr Blood Cancer; 2015 Nov; 62(11):2021-4. PubMed ID: 26138905
[TBL] [Abstract][Full Text] [Related]
28. Clinical and cytogenetic characterisation of a patient with Down syndrome resulting from a 21q22.1-->qter duplication.
Nadal M; Vigo CG; Melaragno MI; Andrade JA; Alonso LG; Brunoni D; Pritchard M; Estivill X
J Med Genet; 2001 Jan; 38(1):73-6. PubMed ID: 11334012
[No Abstract] [Full Text] [Related]
29. Myeloproliferative disease of childhood associated with a trisomy 21 clone.
Tabachnik E; Garty R; Zaizov R; Chemke J
Acta Haematol; 1979; 62(2):90-3. PubMed ID: 119407
[TBL] [Abstract][Full Text] [Related]
30. [An analysis of human marker chromosomes originating from chromosome 21 by using in situ hybridization].
Zerova TE; Baronova EV; Gorovenko NG; Koblianskaia GN; Buzhievskaia TI; Vorsanova SG; Iurov IuB
Tsitol Genet; 1995; 29(5):41-8. PubMed ID: 8721845
[TBL] [Abstract][Full Text] [Related]
31. Gain of 9p due to an unbalanced rearrangement der(9;18): a recurrent clonal abnormality in chronic myeloproliferative disorders.
Bacher U; Haferlach T; Schoch C
Cancer Genet Cytogenet; 2005 Jul; 160(2):179-83. PubMed ID: 15993276
[TBL] [Abstract][Full Text] [Related]
32. Tetrasomy 21 pter-->q22.1 and Down syndrome: molecular definition of the region.
Daumer-Haas C; Schuffenhauer S; Walther JU; Schipper RD; Porstmann T; Korenberg JR
Am J Med Genet; 1994 Dec; 53(4):359-65. PubMed ID: 7532356
[TBL] [Abstract][Full Text] [Related]
33. Molecular analysis of chromosome 21 in a patient with a phenotype of Down syndrome and apparently normal karyotype.
Ahlbom BE; Goetz P; Korenberg JR; Pettersson U; Seemanova E; Wadelius C; Zech L; Annerén G
Am J Med Genet; 1996 Jun; 63(4):566-72. PubMed ID: 8826436
[TBL] [Abstract][Full Text] [Related]
34. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
Bernell P; Jacobsson B; Nordgren A; Hast R
Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
[TBL] [Abstract][Full Text] [Related]
35. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review.
D'Angelo G; Merlo P
Lab Hematol; 2003; 9(1):38-41. PubMed ID: 12661826
[TBL] [Abstract][Full Text] [Related]
36. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
[TBL] [Abstract][Full Text] [Related]
37. Isolation of a cosmid clone corresponding to an inv(21) breakpoint of a patient with transient abnormal myelopoiesis.
Ohta T; Nakano M; Tsujita T; Abe K; Osoegawa K; Yamagata T; Yoshiura K; Jinno Y; Soeda E; Nakamura Y; Niikawa N
Am J Hum Genet; 1996 Mar; 58(3):544-50. PubMed ID: 8644714
[TBL] [Abstract][Full Text] [Related]
38. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
[TBL] [Abstract][Full Text] [Related]
39. Prenatal diagnosis of trisomy 21 without the Down syndrome phenotype.
Aguinaga M; Razo G; Castro J; Mayén-Molina DG
Prenat Diagn; 2006 Dec; 26(12):1168-71. PubMed ID: 17042031
[TBL] [Abstract][Full Text] [Related]
40. Transient abnormal myelopoiesis of infancy associated with trisomy 21.
Homans AC; Verissimo AM; Vlacha V
Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):392-9. PubMed ID: 8214361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
